Structures by: Seiler V. K.
Total: 41
C19H20NO,Cl
C19H20NO,Cl
CrystEngComm (2018) 20, 24 3318
a=8.3825(4)Å b=14.3515(8)Å c=13.3425(7)Å
α=90° β=96.835(5)° γ=90°
C19H20NO,Br
C19H20NO,Br
CrystEngComm (2018) 20, 24 3318
a=8.3080(4)Å b=13.9039(8)Å c=13.6580(6)Å
α=90° β=96.642(4)° γ=90°
C23H22NO,NO3
C23H22NO,NO3
CrystEngComm (2018) 20, 24 3318
a=14.9120(4)Å b=6.9922(2)Å c=37.2099(13)Å
α=90° β=90° γ=90°
C19H20NO,NO3
C19H20NO,NO3
CrystEngComm (2018) 20, 24 3318
a=10.4953(9)Å b=19.9612(19)Å c=8.1903(7)Å
α=90° β=90° γ=90°
C20H22NO21,Cl1,2(H2O)
C20H22NO21,Cl1,2(H2O)
CrystEngComm (2018) 20, 24 3318
a=11.5183(3)Å b=24.4350(7)Å c=7.1002(2)Å
α=90° β=98.786(3)° γ=90°
C20H22NO2,NO3,H2O
C20H22NO2,NO3,H2O
CrystEngComm (2018) 20, 24 3318
a=10.9418(7)Å b=22.2438(13)Å c=8.0740(6)Å
α=90° β=99.632(7)° γ=90°
Tetrakis(2-[(E)-2-(2-hydroxy-3-methoxyphenyl)ethenyl]-1,3,3-trimethyl-3H-indol-1-ium) tris(phosphoric acid) nonahydrate tetradihydrogen phosphate
2(C20H22NO2),2(H2O4P),1.5(H3O4P),4.5(H2O)
CrystEngComm (2018) 20, 24 3318
a=12.0289(5)Å b=12.4435(5)Å c=17.4047(7)Å
α=76.128(4)° β=81.814(4)° γ=79.953(4)°
C23H22NO1,Cl1
C23H22NO1,Cl1
CrystEngComm (2018) 20, 24 3318
a=17.6960(6)Å b=15.1030(4)Å c=6.9665(3)Å
α=90° β=92.410(4)° γ=90°
C19H21BrNO1.50
C19H21BrNO1.50
CrystEngComm (2018) 20, 24 3318
a=12.8779(5)Å b=10.4911(5)Å c=12.8498(7)Å
α=90° β=94.836(4)° γ=90°
2-[(E)-2-(2-hydroxy-5-nitrophenyl)ethenyl]-1,3,3-trimethyl-3H-indol-1-ium hydrogen sulfate
C19H19N2O3,HO4S
CrystEngComm (2018) 20, 24 3318
a=11.768(3)Å b=25.295(5)Å c=7.006(2)Å
α=90° β=104.70(3)° γ=90°
C19H19N2O3,NO3
C19H19N2O3,NO3
CrystEngComm (2018) 20, 24 3318
a=7.227(3)Å b=10.0542(10)Å c=12.687(3)Å
α=80.825(14)° β=89.00(2)° γ=88.089(18)°
C19H17N3O5
C19H17N3O5
CrystEngComm (2018) 20, 24 3318
a=18.8741(12)Å b=6.2632(3)Å c=14.2571(7)Å
α=90° β=98.548(6)° γ=90°
C23H22NO,Br
C23H22NO,Br
CrystEngComm (2018) 20, 24 3318
a=17.8583(18)Å b=15.1686(10)Å c=6.9757(3)Å
α=90° β=93.704(7)° γ=90°
C20H22NO2,HO4S
C20H22NO2,HO4S
CrystEngComm (2018) 20, 24 3318
a=7.8327(5)Å b=16.0190(13)Å c=15.1017(19)Å
α=90° β=90° γ=90°
4(C19H19N2O3),2(H3O4P),4(H2O4P),4(C2H3N),H2O
4(C19H19N2O3),2(H3O4P),4(H2O4P),4(C2H3N),H2O
CrystEngComm (2018) 20, 24 3318
a=12.6562(3)Å b=13.9654(7)Å c=28.3803(12)Å
α=83.572(4)° β=79.127(3)° γ=78.777(3)°
C38H38Br4N2O2Zn2
C38H38Br4N2O2Zn2
CrystEngComm (2019) 21, 33 4925
a=9.3000(8)Å b=9.3023(8)Å c=11.3137(10)Å
α=94.166(7)° β=108.407(8)° γ=96.344(7)°
C46H42Cl4N2O2Zn2,C3H6O
C46H42Cl4N2O2Zn2,C3H6O
CrystEngComm (2019) 21, 33 4925
a=8.8991(3)Å b=13.0969(4)Å c=19.8630(6)Å
α=90° β=90.033(3)° γ=90°
C19H18Cl2N2O3Zn
C19H18Cl2N2O3Zn
CrystEngComm (2019) 21, 33 4925
a=17.659(4)Å b=15.216(3)Å c=6.9834(12)Å
α=90° β=94.06(2)° γ=90°
C19H20NO,Cl3H2OZn
C19H20NO,Cl3H2OZn
CrystEngComm (2019) 21, 33 4925
a=8.2890(5)Å b=21.5395(16)Å c=12.2257(11)Å
α=90° β=97.748(7)° γ=90°
C19H20Cl2N2O4Zn,2(H2O)
C19H20Cl2N2O4Zn,2(H2O)
CrystEngComm (2019) 21, 33 4925
a=12.388(6)Å b=13.671(7)Å c=14.855(8)Å
α=108.02(5)° β=101.20(4)° γ=101.01(4)°
Zinc(2+) ion bis(1,3,3-trimethyl-2-[(E)-2-(5-nitro-2-oxidophenyl)ethenyl]-3H-indol-1-ium) dichloride
2(C19H18N2O3),Zn2,2Cl1
CrystEngComm (2019) 21, 33 4925
a=8.86510(16)Å b=14.8667(4)Å c=15.2523(5)Å
α=113.831(3)° β=94.587(2)° γ=91.7161(19)°
Dizinc(2+) ion bis(1,3,3-trimethyl-2-[(E)-2-(2-oxidonaphthalen-1-yl)ethenyl]-3H-indol-1-ium) tetrabromide acetone solvate
C46H42Br4N2O2Zn2,C3H6O
CrystEngComm (2019) 21, 33 4925
a=8.97440(14)Å b=12.9849(2)Å c=20.5608(3)Å
α=90° β=91.4476(14)° γ=90°
2(C22H27Cl2NO3Zn),H2O
2(C22H27Cl2NO3Zn),H2O
CrystEngComm (2019) 21, 33 4925
a=21.9384(11)Å b=9.7692(4)Å c=21.2029(10)Å
α=90° β=97.634(5)° γ=90°
C19H18Br2N2O3Zn
C19H18Br2N2O3Zn
CrystEngComm (2019) 21, 33 4925
a=17.517(7)Å b=15.290(4)Å c=7.252(2)Å
α=90° β=92.47(3)° γ=90°
C19H20Cl2N2O4Zn,2(H2O)
C19H20Cl2N2O4Zn,2(H2O)
CrystEngComm (2019) 21, 33 4925
a=6.5663(8)Å b=15.8090(12)Å c=20.1333(15)Å
α=90° β=90° γ=90°
2(C21H21Br2N3O3Zn),C2H3N
2(C21H21Br2N3O3Zn),C2H3N
CrystEngComm (2019) 21, 33 4925
a=14.4022(7)Å b=13.0338(6)Å c=26.6165(16)Å
α=90° β=99.770(6)° γ=90°
2(C19H19N2O3),Cl4Co,H2O
2(C19H19N2O3),Cl4Co,H2O
CrystEngComm (2019) 21, 33 4925
a=11.6156(11)Å b=13.0124(6)Å c=14.0058(14)Å
α=77.862(6)° β=76.661(8)° γ=87.030(6)°
C19H18Cl3CoN2O3,C19H19N2O3
C19H18Cl3CoN2O3,C19H19N2O3
CrystEngComm (2019) 21, 33 4925
a=11.9195(9)Å b=12.6137(7)Å c=25.1143(14)Å
α=90° β=97.136(6)° γ=90°
C20.07H21.22Br2.46N2O3.54Zn,C19H18.46N2O3
C20.07H21.22Br2.46N2O3.54Zn,C19H18.46N2O3
CrystEngComm (2019) 21, 33 4925
a=11.8302(4)Å b=12.7363(3)Å c=24.6870(9)Å
α=90° β=98.600(3)° γ=90°
2-[(E)-2-(2-hydroxy-3-methoxyphenyl)ethenyl]-1,3,3-trimethyl-3H-indol-1-ium dihydrate bromide
C20H22NO21,Br1,2(H2O)
CrystEngComm (2018) 20, 24 3318
a=11.5976(3)Å b=23.9015(6)Å c=7.36093(15)Å
α=90° β=98.766(2)° γ=90°
Zinc(2+) ion 2-[(E)-2-(3-methoxy-2-oxidophenyl)ethenyl]-1,3,3-trimethyl-3H-indol-1-ium ethanol dibromide
C20H20NO2,Zn2,2(Br1),C2H6O1
CrystEngComm (2019) 21, 33 4925
a=10.1512(3)Å b=12.0717(4)Å c=21.8754(7)Å
α=84.876(3)° β=77.406(2)° γ=65.333(3)°
C19H18Cl3N2O3Zn,C19H19N2O3
C19H18Cl3N2O3Zn,C19H19N2O3
CrystEngComm (2019) 21, 33 4925
a=11.8909(7)Å b=12.6582(7)Å c=25.0471(16)Å
α=90° β=98.073(6)° γ=90°
C38H36Br2N4O6Zn
C38H36Br2N4O6Zn
CrystEngComm (2019) 21, 33 4925
a=9.1737(6)Å b=14.9690(14)Å c=15.421(2)Å
α=116.717(11)° β=98.405(8)° γ=89.487(7)°
5-(Hydroxymethyl)uracil
C5H6N2O3
Acta Crystallographica Section C (2016) 72, 5 379-388
a=4.874(3)Å b=7.663(2)Å c=8.325(3)Å
α=66.97(2)° β=88.09(2)° γ=87.07(2)°
5-Carboxyuracil <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C5H4N2O4,C3H7NO
Acta Crystallographica Section C (2016) 72, 5 379-388
a=8.671(3)Å b=12.394(2)Å c=9.381(2)Å
α=90° β=90.17(2)° γ=90°
5-Carboxyuracil dimethyl sulfoxide monosolvate
C5H4N2O4,C2H6OS
Acta Crystallographica Section C (2016) 72, 5 379-388
a=6.9341(9)Å b=6.9015(5)Å c=20.919(3)Å
α=90° β=96.604(10)° γ=90°
5-Carboxyuracil <i>N</i>,<i>N</i>-dimethylacetamide monosolvate
C5H4N2O4,C4H9NO
Acta Crystallographica Section C (2016) 72, 5 379-388
a=11.7707(19)Å b=6.1053(10)Å c=15.271(3)Å
α=90° β=90.858(13)° γ=90°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid dimethylformamide monosolvate
C5H4N2O3S,C3H7NO
Acta Crystallographica Section C (2016) 72, 5 379-388
a=10.1742(10)Å b=11.4616(12)Å c=9.9715(11)Å
α=90° β=104.318(8)° γ=90°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid 1,4-dioxane sesquisolvate
C5H4N2O3S,1.5(C4H8O2)
Acta Crystallographica Section C (2016) 72, 5 379-388
a=5.2819(7)Å b=10.3542(12)Å c=13.0071(15)Å
α=89.377(10)° β=85.143(10)° γ=77.700(10)°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
C5H4N2O3S
Acta Crystallographica Section C (2016) 72, 5 379-388
a=11.409(3)Å b=15.552(3)Å c=7.369(2)Å
α=90° β=97.599(19)° γ=90°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid dimethyl sulfoxide monosolvate
C5H4N2O3S,C2H6OS
Acta Crystallographica Section C (2016) 72, 5 379-388
a=7.0475(9)Å b=8.9534(12)Å c=9.2802(13)Å
α=115.790(10)° β=95.753(11)° γ=95.791(10)°